Liquidia Corporation (LQDA) Ownership
LQDA ownership summary
as of October 17, 2026- Institutions
- 81.9% of shares outstanding
- Insiders
- 9.21% of shares outstanding
- Shares outstanding
- 89.5M
- Float
- 65.2M shares available to trade
- Short interest
- 17.52% 12.6M shares short
- Days to cover
- 5.68 short interest up 2.1% vs prior month
- Institutions 81.86%
- Insiders 9.21%
- Other investors 8.93%
LQDA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 12.05% | 10.8M | $370.6M | +5.3M (+96.5%) | June 30, 2026 |
| 2 | Farallon Capital Management, L.L.C. | 9.35% | 8.4M | $287.3M | −291,000 (−3.4%) | June 30, 2026 |
| 3 | Caligan Partners LP | 9.07% | 8.1M | $278.9M | — | June 30, 2026 |
| 4 | Findell Capital Management LLC | 3.91% | 3.5M | $120.3M | — | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 3.51% | 3.1M | $107.8M | +212,238 (+7.3%) | June 30, 2026 |
| 6 | State Street Corp | 3.39% | 3.0M | $104.1M | +1.1M (+61.1%) | June 30, 2026 |
| 7 | Opaleye Management Inc | 2.73% | 2.4M | $84.1M | −97,500 (−3.8%) | June 30, 2026 |
| 8 | Geode Capital Management, LLC | 2.37% | 2.1M | $72.9M | +192,321 (+10.0%) | June 30, 2026 |
| 9 | Bank of America Corp | 2.23% | 2.0M | $68.4M | −296,226 (−12.9%) | June 30, 2026 |
| 10 | T. Rowe Price Associates, Inc. | 2.17% | 1.9M | $66.7M | +987,213 (+103.6%) | June 30, 2026 |
| 11 | Vanguard Portfolio Management, LLC | 1.71% | 1.5M | $52.6M | +899,526 (+142.2%) | June 30, 2026 |
| 12 | Caprock Group Inc | 1.57% | 1.4M | $48.4M | +42,524 (+3.1%) | June 30, 2026 |
| 13 | MPM Oncology Impact Management LP | 1.55% | 1.4M | $47.6M | −18,984 (−1.4%) | June 30, 2026 |
| 14 | D. E. Shaw & Co LP | 1.42% | 1.3M | $43.5M | +394,641 (+45.2%) | June 30, 2026 |
| 15 | Fuller & Thaler Asset Management Inc | 1.35% | 1.2M | $41.5M | +1.2M (0.0%) | June 30, 2026 |
| 16 | The Goldman Sachs Group Inc | 1.07% | 959K | $32.9M | +146,902 (+18.1%) | June 30, 2026 |
| 17 | Federated Hermes Inc | 0.91% | 816K | $28.0M | +377,420 (+86.0%) | June 30, 2026 |
| 18 | Northern Trust Corp | 0.79% | 709K | $24.4M | +129,188 (+22.3%) | June 30, 2026 |
| 19 | Charles Schwab Investment Management Inc | 0.75% | 674K | $23.2M | +116,833 (+21.0%) | June 30, 2026 |
| 20 | Morgan Stanley - Brokerage Accounts | 0.74% | 658K | $22.6M | +313,770 (+91.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 14 holders added 11.5M shares and 4 cut 704K.
LQDA top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Core S&P Small-Cap ETF | 4.94% | 4.4M | $152.0M | +957 (+0.0%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 2.53% | 2.3M | $77.8M | −2,669 (−0.1%) | August 31, 2026 |
| 3 | iShares Russell 2000 ETF | 2.04% | 1.8M | $62.7M | −16,006 (−0.9%) | September 30, 2026 |
| 4 | Invesco S&P SmallCap Momentum ETF | 0.94% | 841K | $28.9M | — | September 30, 2026 |
| 5 | Fidelity Small Cap Index | 0.86% | 771K | $26.5M | +6,562 (+0.9%) | July 31, 2026 |
| 6 | iShares S&P Small-Cap 600 Growth ETF | 0.77% | 688K | $23.6M | — | September 30, 2026 |
| 7 | State Street SPDR Port S&P 600 Sm CpETF | 0.76% | 676K | $23.2M | — | September 30, 2026 |
| 8 | iShares Russell 2000 Growth ETF | 0.74% | 660K | $22.7M | −836 (−0.1%) | September 30, 2026 |
| 9 | T. Rowe Price New Horizons | 0.53% | 475K | $16.3M | −19,415 (−3.9%) | August 31, 2026 |
| 10 | State Street® SPDR® S&P 600™ Sm Cp GrETF | 0.48% | 428K | $14.7M | — | September 30, 2026 |
| 11 | American Century Small Cap Growth Inv | 0.46% | 414K | $14.2M | +413,511 (0.0%) | June 30, 2026 |
| 12 | Vanguard Russell 2000 ETF | 0.45% | 406K | $13.9M | +9,588 (+2.4%) | August 31, 2026 |
| 13 | Vanguard Tax-Managed Small Cap Adm | 0.45% | 402K | $13.8M | — | August 31, 2026 |
| 14 | Oberweis Micro-Cap | 0.44% | 392K | $13.5M | +34,900 (+9.8%) | June 30, 2026 |
| 15 | Schwab US Small-Cap ETF™ | 0.44% | 391K | $13.4M | +261 (+0.1%) | September 30, 2026 |
| 16 | T. Rowe Price Health Sciences | 0.41% | 365K | $12.5M | +364,952 (0.0%) | August 31, 2026 |
| 17 | T. Rowe Price Integrated US Sm Gr Eq | 0.40% | 359K | $12.3M | — | August 31, 2026 |
| 18 | Fidelity Extended Market Index | 0.38% | 341K | $11.7M | −3,447 (−1.0%) | August 31, 2026 |
| 19 | Federated Hermes MDT Small Cap Core IS | 0.37% | 331K | $11.4M | +156,983 (+90.3%) | June 30, 2026 |
| 20 | iShares US Pharmaceuticals ETF | 0.30% | 271K | $9.3M | +834 (+0.3%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
LQDA insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-17 | Roger Jeffs | Sell | $40.60 | 18,839 | $764,863 |
| 2026-04-15 | Michael Kaseta | Sell | $40.14 | 139,390 | $5.6M |
| 2026-04-15 | Roger Jeffs | Sell | $40.14 | 25,000 | $1.0M |
| 2026-04-14 | Michael Kaseta | Sell | $40.00 | 3,000 | $120,000 |
| 2026-04-14 | Roger Jeffs | Sell | $40.00 | 3,300 | $132,000 |
| 2026-04-13 | Russell Schundler | Sell | $38.37 | 13,692 | $525,362 |
| 2026-04-13 | Scott Moomaw | Sell | $38.34 | 10,547 | $404,372 |
| 2026-04-13 | Sarah Krepp | Sell | $38.37 | 4,557 | $174,852 |
| 2026-04-13 | Roger Jeffs | Sell | $38.37 | 32,744 | $1.3M |
| 2026-04-13 | Rajeev Saggar | Sell | $38.37 | 9,220 | $353,771 |
| 2026-04-13 | Michael Kaseta | Sell | $38.37 | 18,958 | $727,418 |
| 2026-04-13 | Jason Adair | Sell | $38.37 | 7,301 | $280,139 |
| 2026-04-13 | Dana Boyle | Sell | $38.37 | 5,101 | $195,725 |
| 2026-04-10 | Michael Kaseta | Sell | $40.14 | 23,821 | $956,175 |
| 2026-04-10 | Roger Jeffs | Sell | $40.12 | 21,433 | $859,892 |
| 2026-04-09 | Michael Kaseta | Sell | $40.24 | 133,789 | $5.4M |
| 2026-04-09 | Roger Jeffs | Sell | $40.12 | 25,000 | $1.0M |
| 2026-03-27 | Stephen M Bloch | Sell | $35.94 | 62,550 | $2.2M |
| 2026-03-23 | Scott Moomaw | Sell | $36.79 | 18,314 | $673,772 |
| 2026-01-26 | Dana Boyle | Sell | $41.65 | 1,580 | $65,807 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
LQDA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns LQDA
Institutional investors own 81.9% of Liquidia's shares and insiders 9.21%. The largest holder is BlackRock Inc with 12.05% of the shares (10.8M), as of June 30, 2026. Among the top 20 institutions, 14 added shares and 4 reduced their stake in the latest filings. Short interest is 17.52% of the float, or 5.68 days of average trading volume. The share count rose 1,065.2% since 2017.
Related: LQDA analyst forecast, LQDA key metrics. See the LQDA stock overview for the latest quote and news.
LQDA ownership FAQ
Who owns the most Liquidia stock?
The largest shareholders of Liquidia are BlackRock Inc (12.05%), Farallon Capital Management, L.L.C. (9.35%), Caligan Partners LP (9.07%), Findell Capital Management LLC (3.91%), Vanguard Capital Management, LLC (3.51%).
What percentage of Liquidia is owned by institutions?
Institutions hold 81.9% of Liquidia's shares outstanding; insiders hold 9.21%.
Which funds own Liquidia?
The largest fund holders of Liquidia are iShares Core S&P Small-Cap ETF (4.94%), Vanguard MStar Total Stk Mkt Idx Invest (2.53%), iShares Russell 2000 ETF (2.04%), Invesco S&P SmallCap Momentum ETF (0.94%), Fidelity Small Cap Index (0.86%).
What is Liquidia's short interest?
12.6M shares of Liquidia were sold short, 17.52% of the float; at the average daily volume it would take 5.68 days to cover.
Are insiders buying or selling Liquidia?
Of the latest 20 reported insider transactions in Liquidia (since January 26, 2026), 0 were purchases and 20 were sales.
How many shares of Liquidia are outstanding?
Liquidia has 89.5M shares outstanding, of which 65.2M are in the public float.